Pacritinib to inhibit JAK/STAT signaling in refractory metastatic colon and rectal cancer.
about
Pacritinib to inhibit JAK/STAT signaling in refractory metastatic colon and rectal cancer.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh-hant
name
Pacritinib to inhibit JAK/STAT ...... tatic colon and rectal cancer.
@en
Pacritinib to inhibit JAK/STAT ...... tatic colon and rectal cancer.
@nl
type
label
Pacritinib to inhibit JAK/STAT ...... tatic colon and rectal cancer.
@en
Pacritinib to inhibit JAK/STAT ...... tatic colon and rectal cancer.
@nl
prefLabel
Pacritinib to inhibit JAK/STAT ...... tatic colon and rectal cancer.
@en
Pacritinib to inhibit JAK/STAT ...... tatic colon and rectal cancer.
@nl
P2093
P2860
P356
P1476
Pacritinib to inhibit JAK/STAT ...... tatic colon and rectal cancer.
@en
P2093
A Craig Lockhart
Amberly Brown
Andrea Wang-Gillam
Benjamin R Tan
Emily Ratchford
Haeseong Park
Kathryn Trinkaus
Katrina S Pedersen
Kian-Huat Lim
P2860
P304
P356
10.21037/JGO.2017.08.16
P577
2017-12-01T00:00:00Z